Featured Research

from universities, journals, and other organizations

Walk, Don't Drive: Community Promotion Of Physical Activity Has Two-fold Benefit

Date:
August 3, 2009
Source:
George Mason University
Summary:
Reducing short-distance car trips has many benefits -- it decreases car accidents, has positive benefits for the environment, and increases physical health and activity, says an expert in climate change.

About half of the car trips in the U.S. are less than five miles—a distance easily navigated by walking or cycling. Reducing short-distance car trips has many benefits—it decreases car accidents, has positive benefits for the environment and increases physical health and activity, says communication professor Edward Maibach of George Mason University. An expert in climate change communication research, Maibach says that community leaders should make promotion of physical activity a priority.

“There are lots of proven low-cost options that communities can use to encourage people to get out of their cars and walk or ride instead,” he says. “Use of these options helps people remain healthy (by promoting physical activity and reducing obesity) and helps reduce heat-trapping pollutants that cause global warming.”

In a recent article in the journal Preventative Medicine, Maibach suggests that policy makers and government officials at all levels should look at communication, marketing and policy enhancements that can be implemented with relative ease to promote active transport.

Maibach cites the Web site Active Living by Design as showcasing many examples of successful programs such as city-bike sharing, customized walking or cycling maps and grassroots campaigns.

“One of my favorite examples is ‘walking school buses’ in which children and a few parents walk together to the local school,” says Maibach.

He also suggests policy changes such as reducing speed limits, giving cyclists priority at intersections and closing some roads to cars, can also encourage people to consider alternative ways of commuting.

“There is no one magic bullet. All of these examples can be effective here in the U.S., and all should be implemented in as many communities as possible. The more that are implemented, the more we will wean people away from sole reliance on their cars when they could be walking and/or riding, and improving their health as a result.”

Maibach is the director of the Center for Climate Change Communication at George Mason University. His work over the past 25 years has helped define the fields of public health communication and social marketing, and his book, Designing Health Messages: Approaches from Communication Theory and Public Health Practice, is widely used by academics and practitioners alike.


Story Source:

The above story is based on materials provided by George Mason University. Note: Materials may be edited for content and length.


Cite This Page:

George Mason University. "Walk, Don't Drive: Community Promotion Of Physical Activity Has Two-fold Benefit." ScienceDaily. ScienceDaily, 3 August 2009. <www.sciencedaily.com/releases/2009/08/090803185726.htm>.
George Mason University. (2009, August 3). Walk, Don't Drive: Community Promotion Of Physical Activity Has Two-fold Benefit. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/08/090803185726.htm
George Mason University. "Walk, Don't Drive: Community Promotion Of Physical Activity Has Two-fold Benefit." ScienceDaily. www.sciencedaily.com/releases/2009/08/090803185726.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins